Betlej, Thomas

Betlej, Thomas was paid $3.52M by Medicaid between Jan 2018 and Dec 2024, across 123 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 22% of everything it billed.

Compared with peers

Next to other Specialist providers in Illinois

Rank by total paid#6 of 273

Median peer was paid$32K

This provider vs. median110×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	404	$11K
2019	59,908	$316K
2020	109,474	$926K
2021	96,623	$801K
2022	83,957	$547K
2023	83,683	$468K
2024incomplete	80,381	$455K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	22%	16,275	14,219	$788K
80053	Comprehensive metabolic panel	9.4%	64,940	50,564	$331K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	6.4%	78,886	57,565	$224K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	5.9%	9,841	9,071	$208K
84443	Thyroid stimulating hormone (TSH)	5.6%	24,279	23,012	$197K
88305	Level IV - Surgical pathology, gross and microscopic examination	3.1%	2,781	2,616	$108K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	2.5%	11,370	10,567	$89K
87088		2.5%	16,475	14,763	$88K
80061	Lipid panel	2.3%	21,629	20,165	$80K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	1.9%	4,704	4,524	$67K
80306		1.8%	10,923	9,026	$65K
86780		1.8%	7,771	7,267	$64K

111 more codes

87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	1.6%	1,009	$57K
87040		1.5%	4,752	$52K
80048	Basic metabolic panel (calcium, ionized)	1.4%	12,387	$51K
82805		1.3%	2,250	$47K
86003		1.3%	1,208	$46K
82607		1.3%	7,466	$44K
G0475	Hiv antigen/antibody, combination assay, screening	1.2%	4,214	$41K
83036	Hemoglobin; glycosylated (A1C)	1.1%	12,391	$39K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	1.1%	1,772	$38K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	1.1%	1,766	$38K
84484		<1%	6,830	$35K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	4,053	$31K
88307		<1%	543	$30K
83880		<1%	2,709	$30K
81001		<1%	21,216	$30K
87186		<1%	4,881	$29K
82746		<1%	5,053	$29K
81025		<1%	11,419	$25K
84439		<1%	5,757	$25K
83690		<1%	7,163	$24K
87070		<1%	6,956	$22K
86850		<1%	6,935	$20K
G0472	Hepatitis c antibody screening, for individual at high risk and other covered indication(s)	<1%	1,408	$19K
83970		<1%	1,140	$18K
82728		<1%	4,418	$18K
86901		<1%	7,980	$17K
83550		<1%	3,681	$15K
87081		<1%	5,009	$14K
85730		<1%	4,211	$14K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	322	$14K
86038		<1%	1,812	$14K
85027		<1%	4,858	$14K
84702		<1%	3,062	$13K
86900		<1%	7,812	$13K
85610		<1%	6,687	$13K
82570		<1%	5,531	$13K
82550		<1%	4,281	$12K
86225		<1%	2,013	$12K
80069		<1%	2,800	$12K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	241	$10K
86140		<1%	4,402	$10K
80164		<1%	2,209	$10K
85379		<1%	2,441	$9K
86762		<1%	2,041	$9K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	1,118	$8K
80076		<1%	1,873	$7K
87340		<1%	1,119	$7K
84153		<1%	1,047	$7K
82784		<1%	1,086	$6K
80074		<1%	277	$5K
87486		<1%	222	$5K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	265	$5K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	272	$5K
87493		<1%	217	$5K
84100		<1%	2,017	$5K
87280		<1%	596	$4K
84146		<1%	647	$4K
84403		<1%	306	$4K
85652		<1%	2,991	$4K
83615		<1%	1,261	$4K
87045		<1%	611	$4K
82150		<1%	1,076	$3K
82950		<1%	1,484	$3K
84550		<1%	1,516	$3K
86430		<1%	984	$3K
83001		<1%	300	$3K
87631		<1%	78	$3K
87210		<1%	1,044	$2K
83540		<1%	731	$2K
88304		<1%	123	$2K
80202		<1%	289	$2K
88342		<1%	101	$2K
82248		<1%	906	$2K
87324		<1%	242	$2K
81003		<1%	1,471	$2K
84156		<1%	1,274	$1K
88141		<1%	227	$1K
86880		<1%	564	$1K
84145		<1%	598	$1K
84480		<1%	287	$1K
85045		<1%	905	$1K
80050	General health panel	<1%	64	$1K
84165		<1%	205	$1K
82947		<1%	628	$1K
87449		<1%	153	$1K
82247		<1%	519	$1K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	55	$934.04
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	23	$868.82
82810		<1%	266	$821.29
82553		<1%	155	$641.75
82140		<1%	151	$619.49
0240U		<1%	20	$500.00
80178		<1%	137	$429.01
83002		<1%	77	$399.34
87425		<1%	54	$392.75
85060		<1%	26	$356.82
82951		<1%	53	$315.52
85018		<1%	229	$276.13
89051		<1%	67	$198.61
84157		<1%	139	$161.58
82952		<1%	53	$99.32
82565		<1%	36	$83.88
84450		<1%	32	$79.05
84460		<1%	35	$74.64
84520		<1%	36	$69.48
87205		<1%	30	$61.25
89055		<1%	40	$58.11
87177		<1%	12	$39.60
83930		<1%	15	$37.30
86885		<1%	12	$36.60
87106		0%	20	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.